Correction of murine hemophilia A following nonmyeloablative transplantation of hematopoietic stem cells engineered to encode an enhanced human factor VIII variant using a safety-augmented retroviral vector

Document Type

Journal Article

Publication Date

2009

Journal

Blood

Volume

114

Issue

3

Inclusive Pages

526-34

This document is currently not available here.

Share

COinS